Skip to main content

Mitral Valve Prolapse Echo and Auscultation

Mitral Valve Prolapse: A Comprehensive Review



Mitral Valve Prolapse (MVP) is a common valvular heart condition characterized by the displacement of the mitral valve leaflets into the left atrium during systole. This article provides an in-depth look at the diagnosis, echo findings, and auscultation maneuvers used to identify MVP.


Pathophysiology


In MVP, the mitral valve leaflets bulge backward into the left atrium due to:


1. Myxomatous degeneration: Thickening and redundancy of the valve leaflets.

2. Chordal elongation: Stretching or rupture of the chordae tendineae.


Echo Findings


Echocardiography is the primary diagnostic tool for MVP. Key findings include:


1. Leaflet displacement: > 2 mm displacement of the leaflets beyond the mitral annular plane.

2. Leaflet thickening: Thickening of the leaflets (> 5 mm).

3. Mitral regurgitation: Color Doppler assessment of regurgitant flow.

4. Left atrial enlargement: Enlargement of the left atrium due to chronic regurgitation.


Auscultation Maneuvers


Physical examination plays a crucial role in diagnosing MVP. Auscultation maneuvers include:


1. Mid-systolic click: A high-pitched sound heard best at the apex.

2. Late systolic murmur: A murmur that peaks in late systole, often associated with mitral regurgitation.

3. Valsalva maneuver: Decreases left ventricular volume, increasing the intensity of the murmur.

4. Squatting: Increases left ventricular volume, decreasing the intensity of the murmur.


Clinical Implications


MVP can lead to:


1. Mitral regurgitation: Chronic regurgitation can lead to left ventricular dysfunction.

2. Atrial fibrillation: Increased risk of arrhythmias due to left atrial enlargement.

3. Endocarditis: Increased risk of infective endocarditis.


Management


Treatment strategies for MVP include:


1. Monitoring: Regular echocardiographic follow-up.

2. Medications: Beta blockers or anti-arrhythmics for symptom management.

3. Surgery: Mitral valve repair or replacement in severe cases.


By understanding the technical aspects of MVP, clinicians can provide accurate diagnoses and effective management strategies for patients with this condition.


Visit Echo Library 


Mitral Valve Prolapse (MVP) and Flail Mitral Valve (FMV) are both conditions affecting the mitral valve, but they have distinct differences:


Key Differences


1. Leaflet Motion:

    - MVP: Leaflets bulge backward into the left atrium during systole, but still coapt.

    - FMV: Leaflet or chordae rupture, resulting in severe mitral regurgitation and loss of coaptation.

2. Regurgitation Severity:

    - MVP: Typically mild to moderate mitral regurgitation.

    - FMV: Severe mitral regurgitation due to loss of leaflet coaptation.

3. Echocardiographic Findings:

    - MVP: Leaflet displacement > 2 mm beyond the mitral annular plane.

    - FMV: Visible leaflet or chordae rupture, with severe mitral regurgitation and often a large regurgitant jet.

4. Clinical Presentation:

    - MVP: May be asymptomatic or present with mild symptoms.

    - FMV: Often presents with severe symptoms, such as dyspnea, fatigue, and palpitations, due to acute or severe mitral regurgitation.


Diagnostic Evaluation


1. Echocardiography: Transthoracic echocardiogram (TTE) or transesophageal echocardiogram (TEE) can help diagnose MVP and FMV.

2. Imaging: Careful evaluation of leaflet motion, coaptation, and regurgitant jet severity can help differentiate between MVP and FMV.


Accurate diagnosis and differentiation between MVP and FMV are crucial for guiding management decisions and determining the need for surgical intervention.




#Echocardiography

#Cardiology



Comments

Popular posts from this blog

STEMI ECG Criteria and Universal Definition of MI

  STEMI ECG Criteria and the Universal Definition of Myocardial Infarction: A Complete Guide for Clinicians Early and accurate diagnosis of acute myocardial infarction (AMI) remains the cornerstone of reducing morbidity and mortality in patients presenting with chest pain. Among all forms of acute coronary syndromes (ACS), ST-elevation myocardial infarction (STEMI) represents the most time-sensitive emergency, requiring immediate reperfusion therapy. This article provides a clinically relevant summary of the STEMI ECG criteria and the Universal Definition of Myocardial Infarction (UDMI), based on the latest consensus guidelines from the ESC, ACC, AHA, and WHF. --- 1. Understanding STEMI: Why Accurate ECG Interpretation Matters A 12-lead ECG remains the first and most critical diagnostic test when evaluating suspected myocardial infarction. STEMI is identified when there is evidence of acute coronary artery occlusion, producing transmural ischemia and characteristic ST-segment eleva...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...